carmustine has been researched along with aminolevulinic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Berti, F; Cecchin, D; Della Puppa, A; Gardiman, MP; Lombardi, G; Persano, L; Rolma, G; Rossetto, M; Rustemi, O; Scienza, R; Zagonel, V | 1 |
| Allinson, K; Guilfoyle, M; Harris, F; Jefferies, S; Jena, R; Luney, C; Ma, R; Matys, T; McAbee, JH; Price, S; Qian, W; Sage, W; Santarius, T; Sgubin, D; Sinha, R; Watts, C; Young, A | 1 |
3 other study(ies) available for carmustine and aminolevulinic acid
| Article | Year |
|---|---|
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.
Topics: Adult; Aged; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Combined Modality Therapy; Drug Implants; Female; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2017 |
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
Topics: Aminolevulinic Acid; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Female; Glioblastoma; Humans; Image Enhancement; Kaplan-Meier Estimate; Male; Middle Aged; Neurosurgical Procedures; Retrospective Studies; Treatment Outcome; Wound Infection | 2018 |